Zydus Lifesciences Limited — Others, 25-01-2025: Action(s) taken or orders passed

Zydus Lifesciences has received a Demand Order-In-Original imposing a penalty of ₹10.12 crore related to GST audit issues covering the period from July 2017 to March 2021. The company plans to challenge this order through an appeal, indicating no material financial impact on operations. This development may create a neutral sentiment among investors as the company seeks to contest the ruling, but vigilance is warranted regarding potential future liabilities. Overall, the market could view this as a procedural necessity rather than a significant operational hurdle.